agilon health(US:AGL)2026-02-25 22:30Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $1.57 billion, and for the full year 2025, it was $5.93 billion, reflecting lower than expected risk adjustment revenue and market exits [21][22] - Medical margin for Q4 was negative $74 million and negative $57 million for the full year, impacted by elevated cost trends and risk adjustment effects [23] - Adjusted EBITDA was negative $142 million for Q4 and negative $296 million for the full year, with ACO REACH performance aligning with expectations [24][30] Business Line Data and Key Metrics Changes - Medicare Advantage membership at the end of 2025 was 511,000, while ACO REACH membership was 114,000, affected by a measured growth approach and market exits [20] - The company expects to reduce membership to approximately 430,000 in 2026, including 25,000 members in care coordination fee arrangements [11][26] Market Data and Key Metrics Changes - The company anticipates a gross cost trend of 7.5% for 2026, with net cost trends expected to remain elevated at approximately 7% [29] - The 2026 outlook reflects expected positive impacts from payer contracting, clinical programs, and premium increases, with a projected revenue range of $5.41 billion to $5.58 billion [27][30] Company Strategy and Development Direction - The company is focused on operational discipline and enhancing its Total Care Model, emphasizing partnerships with community-based physicians [5][6] - Strategic initiatives include improving data visibility, clinical pathways, and cost management to support long-term value-based care success [10][19] - The company plans to continue its transformation efforts, aiming for significant profitability improvements in 2026 [19][34] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment with the CMS Advance Notice, believing it does not adequately address rising costs and utilization trends [33] - The company is optimistic about its ability to deliver significant growth and profitability in 2026, driven by actions taken in 2025 [25][32] Other Important Information - The company executed $35 million in operating cost reductions, exceeding previous expectations, to support business objectives [17][30] - The company ended 2025 with $285 million in cash and marketable securities, ahead of expectations [24][32] Q&A Session Summary Question: Clarification on cost trends for 2025 - Management noted that higher inpatient stays in Q3 led to an increase in cost trends, adjusting Q4 to 7.4% [38][39] Question: Insights on ACO REACH and future actions - Management indicated that actions for 2027 would include continued contracting and burden of illness programs, with a focus on improving margins [42][43] Question: Update on fee-for-service trends within ACO REACH - The fee-for-service cost trend has decreased from 8.5% to 8.1%, with trends concentrated in the back half of the year [58][59] Question: Special Needs Plans exposure - Current exposure to Special Needs Plans is around 7%, with no significant mix shift identified yet [80] Question: Membership exits and recontracting - Management stated that exits were broad-based and not concentrated in specific payers, with a focus on future contract negotiations [85][87]